Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1469 of 6351
-
Could poop pills help fight breast cancer? new trial aims to find out
Disease control Not yet recruitingTriple-negative breast cancer (TNBC) is an aggressive form of breast cancer, usually treated with chemotherapy and an immune checkpoint blockade (ICB) in the pre-operative or neoadjuvant phase. However, about 35% of tumors do not respond fully to this therapy, and patient prognos…
Phase 1/2 • Sponsor: Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Slow taper of semaglutide may help keep weight off after stopping
Disease control Recruiting nowSemaglutide is a medication from the class of drugs called glucagon-like peptide-1 agonists that promote weight loss. There is little clinical data on the best strategy to achieve weight maintenance following weight reduction induced by semaglutide. For people who need to discont…
Phase 3 • Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New school program aims to ease autism behavior challenges
Symptom relief Recruiting nowSchools serve a large number of autistic children, yet face two critical gaps that stifle the delivery of evidence-based practices: 1) an intervention gap characterized by limited availability of evidence-based practices educators can use to address externalizing behaviors when t…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
AI reads faces to predict delirium before it strikes
Knowledge-focused Not yet recruitingDelirium has a high incidence rate and significantly affects patient prognosis. Diagnosis often relies on manual assessment, which is subject to strong subjectivity, high rates of missed diagnosis, and poor stability. This study employs non-contact identification technology based…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New scan could spot myeloma lesions better than current tests
Diagnosis Not yet recruitingThis study intends to employ 68Ga-NOTA-BCMA nanobody PET/CT imaging in patients with multiple myeloma to evaluate the feasibility of this technique for myeloma assessment, analyze the correlation between 68Ga-NOTA-BCMA nanobody uptake intensity and disease staging, tumor burden, …
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Robot suits and VR goggles: the new hope for stroke recovery?
Symptom relief Recruiting now* Objective assessment of clinical symptoms, mobility and quality of life changes resulting from stroke and determination of changes resulting from therapies. * Assessment of the rehabilitation effectiveness of traditional high intensity training. * Assessment of the rehabilitati…
Sponsor: Somogy Megyei Kaposi Mór Teaching Hospital • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Heart attack drug aims to save tiny vessels
Disease control Recruiting nowThis is a Phase IIb, multicentric, prospective, randomized (1:1 ratio), open label, and no profit study, with the aim of evaluating the efficacy of late INa current inhibition to improve coronary microcirculation in patients presenting with acute myocardial infarction and multive…
Phase 2/3 • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can PrEP work for people who use drugs? new study aims to find out
Prevention Not yet recruitingThis study looks at how to help people who use drugs start and keep taking medicine that can prevent HIV. The medicine is called PrEP (pre-exposure prophylaxis). The study investigators will use a pill called Descovy (F/TAF), which is already approved by the FDA for HIV preventio…
Sponsor: Heather Henderson • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Could your family history hide a silent brain aneurysm?
Knowledge-focused By invitation onlyThe purpose of this study is to screen first-degree relatives of patients with aneurysmal subarachnoid hemorrhage using magnetic resonance angiography to detect unruptured intracranial aneurysms. This study aims to identify individuals who are at increased risk and determine the …
Sponsor: University of Novi Sad • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New drug may help kids with kidney disease avoid relapses
Disease control Not yet recruitingThis is an open-label randomized controlled trial to evaluate the efficacy and safety of one dose versus two doses of ripertamab in children with frequent relapses or steroid-dependent nephrotic syndrome (FRNS/SDNS).
Sponsor: Mao Jianhua • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a common diabetes drug mend hearts after failure?
Disease control Not yet recruitingThe goal of this clinical trial is to assess the impact of dapagliflozin on myocardial strain in patients with acute heart failure using speckle tracking echocardiography (STE). The main questions it aims to answer are: * Does dapagliflozin improve left ventricular remodeling a…
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New online tool aims to lower suicide risk in LGBTQ+ teens
Symptom relief Recruiting nowSexual and gender minority youth (i.e., LGBTQ+ individuals) are at elevated risk for suicidal thoughts compared to cisgender/heterosexual youth and there is increased demand for programs and treatments tailored to this population. The current study seeks to pilot a brief, online,…
Sponsor: Western University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Bladder cancer combo shows promise in Real-World review
Knowledge-focused Not yet recruitingThe ARON-2PLUS Study is designed as an International Multicentric Retrospective Study to collect global experiences with the use of Enfortumab vedotin plus Pembrolizumab as first-line therapy in patients with locally advanced/metastatic Urothelial Cancer. Two supplementary optio…
Sponsor: Aron Research Foundation Ets • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New blood thinner may be safer after valve surgery
Disease control Not yet recruitingSAFE-HEART is a single-centre, randomized controlled trial comparing the safety and efficiency of Apixaban versus Warfarin in the early period (3 months) after repair or bioprosthetics of the mitral and aortic valve cardiac surgery in patients with atrial fibrillation requiring o…
Phase 3 • Sponsor: Meshalkin Research Institute of Pathology of Circulation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can VR games help stroke survivors walk again?
Symptom relief Recruiting nowStroke is one of the leading causes of long-term disability worldwide, and balance and gait impairments are common in the subacute phase, limiting activity performance and quality of life. Early and intensive rehabilitation during the first six months after stroke is considered c…
Sponsor: Ankara Yildirim Beyazıt University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
AI and wearables join forces to fight muscle loss in seniors
Knowledge-focused OngoingSarcopenia, the age-related decline in muscle mass and function, is a major contributor to frailty, disability, and mortality in older adults. Current diagnostic tools assess muscle quantity or function separately and lack predictive biomarkers, limiting early detection and perso…
Sponsor: Tel Aviv University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Stool test could spot colon cancer early, study hopes
Diagnosis Not yet recruitingColorectal cancer is a major cause of cancer-related morbidity and mortality worldwide, and early detection significantly improves patient outcomes. The fecal immunochemical test (FIT) is a non-invasive stool-based test used for detection of colorectal cancer; however, its diagno…
Sponsor: Sohag University • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New imaging technique could reveal how cancer drugs target tumors
Diagnosis Not yet recruitingAs a humanized bispecific antibody targeting PD-1 and VEGF-A, everolizumab exhibits high specificity for binding PD-1 and VEGF-A in vivo. This critical property was systematically validated in a recent molecular imaging study based on positron emission tomography (PET). The study…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Fluorescent dye reveals hidden brain drains in cadavers
Knowledge-focused Recruiting nowAlzheimer's disease is a condition that affects the brain and is associated with the build-up of waste substances that can damage brain cells. Scientists have recently discovered a natural drainage and cleaning system around the brain, called the meningeal lymphatic system, which…
Sponsor: Germans Trias i Pujol Hospital • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can a natural compound help preserve jawbone after tooth loss?
Disease control Recruiting nowThis study aims to evaluate the clinical and radiographic effects of 0.2% Thymoquinone gel on bone density, bone width, and socket preservation after tooth extraction.
Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC